Article | Open | Published:

Ptf1a inactivation in adult pancreatic acinar cells causes apoptosis through activation of the endoplasmic reticulum stress pathway

Abstract

Pancreas transcription factor 1 subunit alpha (PTF1A) is one of the key regulators in pancreatogenesis. In adults, it transcribes digestive enzymes, but its other functions remain largely unknown. Recent conditional knockout studies using Ptf1aCreER/floxed heterozygous mouse models have found PTF1A contributes to the identity maintenance of acinar cells and prevents tumorigenesis caused by the oncogenic gene Kras. However, Ptf1a heterozygote is known to behave differently from homozygote. To elucidate the effects of Ptf1a homozygous loss, we prepared Elastase-CreERTM; Ptf1afloxed/floxed mice and found that homozygous Ptf1a deletion in adult acinar cells causes severe apoptosis. Electron microscopy revealed endoplasmic reticulum (ER) stress, a known cause of unfolded protein responses (UPR). We confirmed that UPR was upregulated by the activating transcription factor 6 (ATF6) and protein kinase RNA (PKR)-like endoplasmic reticulum kinase (PERK) pathways, but not the inositol requiring enzyme 1 (IRE1) pathway. Furthermore, we detected the expression of CCAAT-enhancer-binding protein (C/EBP) homologous protein (CHOP), a pro-apoptotic factor, indicating the apoptosis was induced through UPR. Our homozygous model helps clarify the role PTF1A has on the homeostasis and pathogenesis of exocrine pancreas in mice.

Introduction

A great volume of study has identified key transcriptional factors that play central roles in cell specification, growth and differentiation during organogenesis. Even in adult cells, sets of transcriptional factors have been reported to shift cell identity to other cell types. Examples include the Yamanaka factors (Oct3/4, Sox2, c-Myc and Klf4) for the creation of iPS cells1,2, the induction of MyoD for the direct reprograming of fibroblasts to myoblasts3, and the induction of Hnf4α and one of Foxa1, Foxa2 or Foxa3 for the transdifferentiation to hepatic cells4. These studies demonstrate the dosage of key transcription factors plays an important role in the regulation of cell behavior.

Ptf1a is an indispensable gene for pancreas formation during organogenesis5,6. Using Cre-mediated lineage tracing experiments, we have previously demonstrated that PTF1A functions as a pancreas-fate determinant; the progeny of Ptf1a-expressing cells are committed to the pancreatic cell fate, whereas the progeny of Ptf1a-deficient cells are committed to the duodenal or bile duct cell fate6. While PTF1A is broadly expressed in nascent pancreatic buds, its expression is gradually confined to exocrine lineage during development and finally to acinar cells5,6,7,8. Analyses of Ptf1a hypomorphic mutant mice revealed that there exists a threshold of the Ptf1a mRNA dosage that allows pancreatic-fate specification and progression along the proper developmental pathway; a reduction of Ptf1a mRNA dosage resulted in a decrease in the number of cells that adopt the pancreatic cell fate, a reduction in cell proliferation of early pancreatic precursors, and an impairment of exocrine cytodifferentiation9.

Despite accumulating information on PTF1A function and PTF1A dosage during embryonic pancreatogenesis, knowledge on the role of PTF1A in adult pancreas is limited. Originally, PTF1A was found as a transcriptional regulator of digestive enzymes such as amylase and elastase in adult acinar cells7. Recently, Krah et al. showed that conditional deletion of Ptf1a in adult acinar cells resulted in ductal metaplasia and made the cells hypersensitive to Kras transformation10. In addition, Hoang et al. reported that Ptf1a deletion in adult acinar cells promotes the expression of genes consistent with stomach lineage11. These reports support the notion that PTF1A is required for maintaining acinar cell identity in adults. However, because the studies used Ptf1aCreER/floxed compound heterozygote mice, the dosage effect of PTF1A remains unexplored. Considering that adult acinar cells in Ptf1a heterozygous mice proliferate more than wild type mice12 and that oncogenic Kras-induced pancreatic cancer progresses more rapidly in Ptf1a heterozygous mice10, the original PTF1A dosage may affect the observations made in these Ptf1a conditional knockout studies.

To explore the dosage effects of PTF1A on adult acinar cells, we used Elastase-CreERTM; Ptf1afloxed/floxed mice to inactivate PTF1A and tracked the fate of Ptf1a-deleted cells by lineage tracing analyses. We found that Ptf1a deletion caused not only a shift in identity to duct cells but also severe apoptosis in acinar cells, which resulted in a rapid reduction of pancreatic mass. Furthermore, we found evidence that the changes were associated with ER stress through activation of the PERK-eIF2α-ATF4 and ATF6 pathways and induction of the pro-apoptotic factor CHOP.

Results

Ptf1a conditional knockout caused pancreatic volume loss and acinar apoptosis

We interbred Elastase-CreERTM and Ptf1afloxed mice to obtain Elastase-CreERTM; Ptf1afloxed/floxed mice (Ptf1a cKO mice) and Elastase-CreERTM; Ptf1a+/+ mice (control) and then crossed them with Rosa26R or Rosa26-RFP mice for lineage tracing (Supplementary Fig. S1) and injected tamoxifen (0.2 mg/g body weight) at the adult stage. We confirmed the efficiency of PTF1A depletion after Cre-mediated recombination by PTF1A immunostaining. PTF1A positivity per lineage-labeled acinar cells was 74.0 ± 6.9% in control mice and 4.4 ± 2.8% in Ptf1a cKO mice on day 3, and 84.2 ± 1.8% in control mice and 1.9 ± 0.4% in Ptf1a cKO mice on day 10, indicating satisfactory depletion of PTF1A in Ptf1a cKO mice (Supplementary Fig. S2a,b).

The pancreas of Ptf1a cKO mice was significantly edematous on day 10 (Fig. 1a), but had already reduced in size by day 3 (Fig. 1b). To account for the size reduction, we observed acinar-to-ductal metaplasia (ADM) in Ptf1a cKO mice10,11. The ADM area was only 2.5% and 1.5% of the whole pancreas on days 3 and 10, respectively, in Ptf1a cKO mice (Supplementary Fig. S3). Considering that the ratio of pancreas weight per body weight of Ptf1a cKO mice was about two thirds that of control mice (Fig. 1b), ADM alone could not explain the pancreatic size reduction. Indeed, TUNEL staining revealed significantly more cell death by day 3 in Ptf1a cKO mice than in control mice, but not on day 10 (Fig. 1c). On the other hand, the number of proliferative (BrdU(+)) cells between control and mutant mice was the same on day 3 and the same on day 10 (Fig. 1c). Thus, accelerated apoptotic cell death by day 3 is presumably the main cause of the pancreatic mass reduction in the mutants.

Figure 1
figure1

Acinar-specific Ptf1a deletion decreased pancreatic volume through activated apoptosis. (a) Representative pancreatic appearance of control and Ptf1a cKO mice on day 10. (b) Relative pancreatic weight per body weight. control, n = 3; Ptf1a cKO, n = 3. (c) The number of TUNEL or BrdU positive acinar cells per mm2 on day 3 or 10. control, n = 3; Ptf1a cKO, n = 3. *P < 0.05.

Consistently, an accelerated cell death of PTF1A-depleted cells was supported by the reduction of lineage-labeled cells in Ptf1a cKO mice on day 10 (43.4 ± 9.5% in control vs. 6.0 ± 2.3% in Ptf1a cKO mice; see Fig. 2a,b). Interestingly, our lineage tracing analyses revealed non-autonomous cell death in the Ptf1a-preserved (X-gal(−)) population of Ptf1a cKO mice on day 3 (Fig. 2c). At the same time, a compensatory proliferation of surrounding Ptf1a-preserved acinar cells in mutant mice was suggested to have occurred by day 3. As shown in Fig. 2d, we detected BrdU(+) cells in the X-gal(−) population. If the proliferative cells were equally distributed independently of Ptf1a deletion, the ratio of X-gal(+) should be equivalent to the ratio of X-gal(+)BrdU(+)cells per total BrdU(+) cells. However, we found the X-gal(+) ratio was higher, suggesting that Ptf1a-preserved cells proliferated more than Ptf1a-deleted cells in mutant pancreata at this stage. Cell death and proliferation seemed to be balanced on day 3, because the percentage of Cre-recombinase activated (X-gal(+)) acinar cells was unchanged between the two mouse types (25.3 ± 5.8% in control and 26.3 ± 4.7% in Ptf1a cKO mice; see Fig. 2a,b). However, compensatory proliferation could not maintain the organ size, and the percentage of X-gal(+) acinar cells was significantly decreased on day 10 (see Figs 1a and 2a,b). Furthermore, the pancreatic volume did not recover by day 20 (Supplementary Fig. S4), which is consistent with a previous report11. The precise mechanism mediating the interaction between Ptf1a-deleted and Ptf1a-preserved cells warrants future investigation.

Figure 2
figure2

Lineage tracing revealed activated apoptosis and compensatory proliferation in Ptf1a cKO pancreata. (a) Representative figures of control and Ptf1a cKO mice on day 3 and day 10 stained by X-gal and Nuclear Fast Red. (b) The ratio of X-gal labeled acinar cells. control, n = 3; Ptf1a cKO, n = 3. (c) Representative figures of TUNEL staining with X-gal and hematoxylin staining, and the number of TUNEL(+) acinar cells per mm2 on day 3. (d) Representative figure of BrdU staining with X-gal and hematoxylin staining, and the ratio of X-gal(+)BrdU(+) cells per total BrdU(+) cells compared with the ratio of X-gal(+)cells in Ptf1a cKO mice on day 3. Arrowheads indicate an X-gal(−)TUNEL(+) nucleus in (c) or X-gal(−)BrdU(+) nuclei in (d) in Ptf1a cKO mice. Scale bars = 100 μm (a) or 25 μm (c,d). *P < 0.05.

Electron microscopy unveiled endoplasmic reticulum stress

To investigate the cell death machinery in Ptf1a cKO mice, we performed electron microscopic analyses (Fig. 3). We noticed the emergence of abnormal acinar cells characterized by significantly dilated ER lumen in Ptf1a cKO pancreata on day 3 (compare Fig. 3b,d). This characteristic phenotype suggests ER stress was caused by an accumulation of unfolded or misfolded proteins within the ER lumen13,14. The ER lumen size was restored to normal by day 10 in mutant mice (compare Fig. 3e–h).

Figure 3
figure3

Activated endoplasmic reticulum stress in acinar cells of Ptf1a cKO mice. Representative findings of electron microscopy in control mice on day 3 (a) in Ptf1a cKO mice on day 3 (c) in control mice on day 10 (e) and in Ptf1a cKO mice on day 10 (g). (b,d,f,h) are magnified images of (a,c,e,g). Note the dilated ER lumen (indicated by red asterisks) in Ptf1a cKO mice on day 3 (d). Scale bars = 2 μm.

ATF6 cleavage was higher in Ptf1a cKO mice on day 3

Our electron microscopy observations prompted us to analyze the unfolded protein response (UPR) to ER stress including activation of the ATF6, IRE1 and PERK-eIF2α-ATF4 pathways, which can contribute to apoptosis15. Western blotting revealed that total ATF6 expression was similar in the two mouse groups on days 3 and 10 (Fig. 4a,b,d,e). However, cleaved ATF6 was more highly expressed in Ptf1a cKO mice on day 3 but not on day 10 (Fig. 4a,c,d,f), indicating that the ATF6 pathway was activated on day 3 but deactivated by day 10 in Ptf1a cKO mice.

Figure 4
figure4

Cleavage of ATF6 was upregulated in Ptf1a cKO mice on day 3 but recovered by day 10. (a) Western blotting of control and Ptf1a cKO mice on day 3. (b) Comparison of the ratio of total ATF6/GAPDH expression in control and Ptf1a cKO mice on day 3. (c) Comparison of the ratio of cleaved ATF6/total ATF6 expression in control and Ptf1a cKO mice on day 3. (d) Western blotting of control and Ptf1a cKO mice on day 10. (e) Comparison of the ratio of total ATF6/GAPDH expression in control and Ptf1a cKO mice on day 10. (f) Comparison of the ratio of cleaved ATF6/total ATF6 expression in control and Ptf1a cKO mice on day 10. f-ATF6: full length ATF6, c-ATF6: cleaved ATF6. control, n = 4; Ptf1a cKO, n = 4. *P < 0.05. The original, unprocessed scans of the blots are shown in Supplementary Fig. S5.

Xbp1 mRNA splicing was suppressed in Ptf1a cKO mice on day 3

Next, we investigated the IRE1 pathway, which splices X-box binding protein 1 (XBP1) mRNA in response to ER stress in mammals16 (Fig. 5). Our RT-PCR analyses revealed a lower ratio of spliced Xbp1 mRNA in Ptf1a cKO mice on day 3 but not on day 10, suggesting that the IRE1 pathway was suppressed on day 3 but recovered by day 10 in Ptf1a cKO mice.

Figure 5
figure5

Splicing of Xbp1 mRNA was suppressed in Ptf1a cKO mice on day 3 but recovered by day 10. (a) Representative electrophoresis of RT-PCR products of unspliced and spliced Xbp1 mRNA on day 3. (b) Comparison of the percentage of spliced Xbp1 mRNA on day 3 in control and Ptf1a cKO mice. control, n = 5; Ptf1a cKO, n = 6. (c) Representative electrophoresis of RT-PCR products of unspliced and spliced Xbp1 mRNA on day 10. (d) Comparison of the percentage of spliced Xbp1 mRNA on day 10 in control and Ptf1a cKO mice. control, n = 6; Ptf1a cKO, n = 5. *P < 0.05. The original, unprocessed scans of the gels are shown in Supplementary Fig. S6.

ATF4 and CHOP were activated in Ptf1a cKO mice on day 3

Finally, we examined the PERK-eIF2α-ATF4 pathway by ATF4 immunostaining. In control mice, no ATF4 signal in acinar cells was observed. On the other hand, in Ptf1a cKO mice, there was sporadic ATF4 expression predominantly in PTF1A-absent cells on day 3 and almost no ATF4 expression on day 10 (Fig. 6a). Thus, both the ATF6 pathway (Fig. 4) and the PERK-eIF2α-ATF4 axis were upregulated on day 3 but returned to normal activation status by day 10 in Ptf1a cKO mice, which is consistent with our electron microscopy observations (Fig. 3). Furthermore, some cells on day 3 showed immunoreactivity for CHOP, a pro-apoptotic factor17,18, but not on day 10 (Fig. 6b). CHOP immunoreactivity was observed in both ATF4(+) and ATF4(−) cells. Considering that CHOP is a downstream target of the ATF6 and PERK-eIF2α-ATF4 pathways19,20, ATF4(−)CHOP(+) cells may represent activation of the ATF6 pathway. Taken together, these findings suggest that acinar cell death in Ptf1a cKO mice is caused by excessive UPR. Intriguingly, we observed rare CHOP-PTF1A double positive cells in the mutants on day 3 (Fig. 6c), suggesting non-autonomous cell death in Ptf1a-preserved cells (Fig. 2c).

Figure 6
figure6

ATF4 and CHOP were upregulated in Ptf1a cKO mice on day 3 but recovered by day 10. Immunofluorescence of (a) PTF1A and ATF4 (b) ATF4 and CHOP, and (c) PTF1A and CHOP with hematoxylin-eosin staining on days 3 and 10. Arrowheads indicate CHOP and ATF4 double positive nuclei in (b) or a PTF1A and CHOP double positive nucleus in (c). Hematoxylin-eosin was stained on the same sections after immunofluorescence. Scale bars = 50 μm.

Discussion

Here we show that conditional Ptf1a loss in adult acinar cells causes ER stress and activates apoptosis pathways to decrease pancreatic size. It is known that the accumulation of unfolded or misfolded proteins in the ER causes ER stress13,14. In response, cells escape from the stress status by activating the PERK-eIF2α-ATF4, ATF6 and IRE1 pathways15. Each of these three pathways has a specific effect on the cell response to ER stress. PERK phosphorylates eIF2α21 to attenuate the translation of most genes except those that have a specific upper open reading frame such as ATF422, thereby preventing additional stress acutely15. Cleaved ATF6 activates an ER chaperone to restore the protein folding machinery20,23. IRE1 splices Xbp1 mRNA to promote protein degradation24 and thus decrease ER stress15. These mechanisms protect the cell from ER stress, but under excessive stress intensity and duration, prolonged expression of ATF4 and cleaved ATF6 upregulates the pro-apoptotic protein CHOP, which promotes cell death15,17,18,19,20. In Ptf1a cKO mice, we confirmed activation of the PERK-eIF2α-ATF4 and ATF6 pathways plus subsequent CHOP upregulation, and suppression of the IRE1 pathway. These findings suggest acinar cells in mutant mice are not in a cytoprotective state.

Unlike in our model, Krah et al. showed no difference in acinar cell death between control and Ptf1a cKO mice on day 1410, while Hoang et al. observed more apoptosis and UPR change in Ptf1a cKO mice than control11. In addition, consistent with the autophagy they detected, they showed that Xbp1 mRNA splicing was upregulated on days 6 and 14, indicating a cytoprotective response. On the other hand, consistent with the ER stress we detected, we showed different UPR on day 3, indicating an apoptotic response. We speculate that the phenotypic differences between ours and previous models might be explained by the original PTF1A dosage before the depletion. In our experiments, PTF1A dosage decreased from the homozygous-to-null status, whereas in previous models the dosage decreased from the heterozygous-to-null status. Therefore, a more dynamic change in PTF1A expression should have occurred in our model. Presumably, adult acinar cells could not adapt to the rapid and massive decrease of PTF1A expression that caused severe ER stress.

At the same time, several observations were consistent with ours and previous reports. For example, we observed ADM in Ptf1a cKO mice. ADM cells may have escaped the apoptotic cell death machinery and survived by discarding their cell identity as acinar cells. Krah et al. provided evidence that CD45(+) immune cells accumulate upon Ptf1a deletion and that caerulein-induced pancreatitis causes more ADM in Ptf1a cKO mice10. Considering that caerulein-induced pancreatitis itself reduces PTF1A expression25 and causes ER stress26 in acute phase, we propose there exists an interdependence among inflammation, ER stress and the maintenance of acinar cell identity or cell death, in which PTF1A expression plays a crucial role. In this study, we observed accelerated apoptosis and compensatory proliferation of the Ptf1a-preserved cells in the mutant pancreata. These observations indicate the competition between Ptf1a-deleted and -preserved cells, in which non-cell autonomous regulation plays a role. The precise mechanism including the identification of responsible signals warrants future investigation.

In summary, we demonstrated that the homozygous-to-null reduction of Ptf1a triggered excessive UPR through activation of the ATF6 and PERK-eIF2α-ATF4 pathways and suppression of the IRE1 pathway in adult acinar cells. Future studies are required to dissect how acinar cells initiate apoptosis or survive (for example, by changing their identity from acinar to duct-like) upon the rapid and dynamic reduction of PTF1A expression.

Methods

Mice

Elastase-CreERTM, Rosa26R, Rosa26-RFP and Ptf1afloxed mice were previously described27,28,29,30. By mating, we obtained Elastase-CreERTM; Ptf1afloxed/floxed; Rosa26R or Rosa26-RFP mice (Ptf1a cKO mice) in which Ptf1a-deleted cells are detected as X-gal(+) or RFP(+) cells after tamoxifen injection. All animal experiments were performed in accordance with the Kyoto University guidelines for animal experiments and approved by the animal research committee of Kyoto University.

Drug injection

For lineage tracing, 8-week-old mice were injected once intraperitoneally with tamoxifen (T5648, Sigma-Aldrich, St. Louis, MO, USA) at 0.2 mg/g body weight. For BrdU staining, mice were injected intraperitoneally with BrdU (Merck Millipore, Billerica, MA, USA) at 2 mg 1 hour before euthanization.

Tissue preparation

All tissue preparations were performed as previously described31 with some modification. Briefly, for X-gal staining, ice-cold fixative solution (4% paraformaldehyde (PFA), 1% glutaraldehyde (GA)/PBS) was perfused into mice, and specimens were immersed into 4% PFA/PBS for 2 hours at 4 °C followed by 30% sucrose/PBS until equilibration and then embedded into O.C.T. compound (Sakura, Osaka, Japan). For raw RFP sections, the fixative solution perfused was 4% PFA/PBS, and specimens were immersed into the same solution for 4 hours at 4 °C followed by 30% sucrose/PBS until equilibration and then embedded into O.C.T. compound. For paraffin sections, the fixative solution perfused was 4% PFA/PBS, and specimens were immersed into the same solution overnight at 4 °C, then dehydrated in graded alcohol, immersed in Histo-Clear (National Diagnostics, Atlanta, GA, USA) and finally embedded into paraffin.

X-gal staining, immunohistochemistry, immunofluorescence and alcian blue staining

Frozen sections were cut into 4-μm-thick slices. For X-gal staining, they were reacted at room temperature overnight as previously reported31 with some modifications. For TUNEL assays, DeadEnd Colorimetric Apoptosis Detection System (Promega Corporation, Madison, WI, USA) was used in accordance with the manufacturer’s protocols. Paraffin sections were cut into 2-μm-thick slices, deparaffinized and rehydrated. For either immunohistochemistry or immunofluorescence, the procedures from antigen retrieval to antibody reaction were done as previously reported32, however, heat induced epitope retrieval was omitted in the cases of raw RFP detection. The primary antibodies used are listed in Supplementary Table S1 and the secondary antibodies in Supplementary Table S2. The slices were treated with DAB Peroxidase Substrate (SK-4100, Vector Laboratories) for immunohistochemistry or with TSA Plus System (PerkinElmer, Waltham, MA, USA) and 4,6-diamidino-2-phenylindole (DAPI) for immunofluorescence. For alcian blue staining, sections were immersed into 3% acetic acid and then reacted with Alcian Blue Stain Solution pH 2.5 (Muto Pure Chemicals, Tokyo, Japan) for 20 minutes. Sections were counterstained by Nuclear Fast Red (Seracare, Milford, MA, USA), hematoxylin and/or eosin (Wako, Osaka, Japan), as previously reported31. Images were visualized using HS All-in-one Fluorescence Microscopy BZ-9000E (Keyence, Osaka, Japan).

Cell counting

For labeled cell assessment, we chose 30 fields (3 random views per section, 10 sections at equal intervals) at ×200 magnification, counted X-gal positive and negative acinar cells (at least 20,000 cells) in each mouse and calculated the ratio. For PTF1A depletion assessment, we counted at least 700 RFP(+) cells from 30 or 50 fields (3 or 5 random views per section, 10 sections at equal intervals) in each mouse. For BrdU and TUNEL analyses, positive cells were counted in 50 fields (5 random views per section, 10 sections at equal intervals).

Alcian blue(+) area evaluation

10 paraffin sections at equal intervals were stained by alcian blue, and whole images were taken. Whole pancreatic and alcian blue(+) areas were enclosed manually and quantified with BZ-H1M software (Keyence).

Electron microscopy

For tissue preparation, 4% PFA and 2% GA/PBS was perfused into mice. Specimens were cut into approximately 1 mm3 sections, immersed into the same solution overnight at 4 °C, and brought to Division of Electron Microscopic Study (DEMS), Center for Anatomical Studies, Graduate School of Medicine, Kyoto University. DEMS conducted the osmium tetroxide postfixation and the preparation of ultrathin sections with uranium staining. The sections were observed using a transmission electron microscope (Hitachi H-7650, Hitachi, Tokyo, Japan).

Western blotting

Whole pancreatic tissues were used. The procedures from lysate preparation to antibody reaction were reported previously32. The primary antibodies used are listed in Supplementary Table S3 and the secondary antibodies in Supplementary Table S4. Chemiluminescence was detected with Chemi-Lumi One Super (Nacalai tesque, Kyoto, Japan) and visualized with ImageQuant LAS 4000 (GE Healthcare, Chicago, IL, USA). The intensity of the bands was quantified with ImageQuant TL software (GE Healthcare), and the intensity ratio was calculated.

RNA isolation and data analysis

Total pancreatic RNA was extracted using RNeasy Mini Kit (Qiagen, Hilden, Germany) in accordance with the manufacturer’s protocols. First strand cDNA synthesis was performed using ReverTra Ace qPCR RT Master Mix (Toyobo, Osaka, Japan). Measurement of the ratio of spliced to total Xbp1 mRNA was performed by RT-PCR using forward primer 5′–AGTTAAGAACACGCTTGGGAAT–3′ and reverse primer 5′–AAGATGTTCTGGGGAGGTGAC–3′. PCR products were 172 bp for unspliced Xbp1 mRNA and 146 bp for spliced Xbp1 mRNA. The products were electrophoresed in 10% acrylamide gel in TBE, stained with ethidium bromide, and visualized with ChemiDoc XRS + system (Bio-Rad Laboratories, Hercules, CA, USA). The intensity of the bands was quantified with Image Lab Software (Bio-Rad Laboratories), and the intensity ratio was calculated.

Statistical analysis

All values are shown as means ± s.e.m. All error bars represent s.e.m. All indices were analyzed using an unpaired t test (two-tailed). P < 0.05 was considered significant.

Additional information

Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  1. 1.

    Takahashi, K. & Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663–76 (2006).

  2. 2.

    Takahashi, K. et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861–72 (2007).

  3. 3.

    Davis, R. L., Weintraub, H. & Lassar, A. B. Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell 51, 987–1000 (1987).

  4. 4.

    Sekiya, S. & Suzuki, A. Direct conversion of mouse fibroblasts to hepatocyte-like cells by defined factors. Nature 475, 390–3 (2011).

  5. 5.

    Krapp, A. et al. The bHLH protein PTF1-p48 is essential for the formation of the exocrine and the correct spatial organization of the endocrine pancreas. Genes Dev 12, 3752–63 (1998).

  6. 6.

    Kawaguchi, Y. et al. The role of the transcriptional regulator Ptf1a in converting intestinal to pancreatic progenitors. Nat Genet 32, 128–34 (2002).

  7. 7.

    Krapp, A. et al. The p48 DNA-binding subunit of transcription factor PTF1 is a new exocrine pancreas-specific basic helix-loop-helix protein. EMBO J 15, 4317–29 (1996).

  8. 8.

    Masui, T. et al. Transcriptional autoregulation controls pancreatic Ptf1a expression during development and adulthood. Mol Cell Biol 28, 5458–68 (2008).

  9. 9.

    Fukuda, A. et al. Reduction of Ptf1a gene dosage causes pancreatic hypoplasia and diabetes in mice. Diabetes 57, 2421–31 (2008).

  10. 10.

    Krah, N.M. et al. The acinar differentiation determinant PTF1A inhibits initiation of pancreatic ductal adenocarcinoma. Elife 4 (2015).

  11. 11.

    Hoang, C. Q. et al. Transcriptional Maintenance of Pancreatic Acinar Identity, Differentiation, and Homeostasis by PTF1A. Mol Cell Biol 36, 3033–3047 (2016).

  12. 12.

    Rodolosse, A. et al. PTF1alpha/p48 transcription factor couples proliferation and differentiation in the exocrine pancreas [corrected]. Gastroenterology 127, 937–49 (2004).

  13. 13.

    Alanen, A., Pira, U., Lassila, O., Roth, J. & Franklin, R. M. Mott cells are plasma cells defective in immunoglobulin secretion. Eur J Immunol 15, 235–42 (1985).

  14. 14.

    Pavelka, M. & Roth, J. Third edition. Functional Ultrastructure: Atlas of Tissue Biology and Pathology, 48–49 (Springer-Verlag Vienna, 2015).

  15. 15.

    Waldron, R. T., Pandol, S., Lugea, A. & Groblewski, G. Endoplasmic reticulum stress and the unfolded protein response in exocrine pancreas physiology and pancreatitis. October 16, 2015 edn (Pancreapedia: Exocrine Pancreas Knowledge Base, https://doi.org/10.3998/panc.2015.41, 2015).

  16. 16.

    Yoshida, H., Matsui, T., Yamamoto, A., Okada, T. & Mori, K. XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor. Cell 107, 881–91 (2001).

  17. 17.

    Friedman, A. D. GADD153/CHOP, a DNA damage-inducible protein, reduced CAAT/enhancer binding protein activities and increased apoptosis in 32D c13 myeloid cells. Cancer Res 56, 3250–6 (1996).

  18. 18.

    Cai, Y. et al. TRAM1 protects AR42J cells from caerulein-induced acute pancreatitis through ER stress-apoptosis pathway. In Vitro Cell Dev Biol Anim 52, 530–6 (2016).

  19. 19.

    Fawcett, T. W., Martindale, J. L., Guyton, K. Z., Hai, T. & Holbrook, N. J. Complexes containing activating transcription factor (ATF)/cAMP-responsive-element-binding protein (CREB) interact with the CCAAT/enhancer-binding protein (C/EBP)-ATF composite site to regulate Gadd153 expression during the stress response. Biochem J 339(Pt 1), 135–41 (1999).

  20. 20.

    Yoshida, H. et al. ATF6 activated by proteolysis binds in the presence of NF-Y (CBF) directly to the cis-acting element responsible for the mammalian unfolded protein response. Mol Cell Biol 20, 6755–67 (2000).

  21. 21.

    Harding, H. P., Zhang, Y. & Ron, D. Protein translation and folding are coupled by an endoplasmic-reticulum-resident kinase. Nature 397, 271–4 (1999).

  22. 22.

    Harding, H. P. et al. Regulated translation initiation controls stress-induced gene expression in mammalian cells. Mol Cell 6, 1099–108 (2000).

  23. 23.

    Haze, K., Yoshida, H., Yanagi, H., Yura, T. & Mori, K. Mammalian transcription factor ATF6 is synthesized as a transmembrane protein and activated by proteolysis in response to endoplasmic reticulum stress. Mol Biol Cell 10, 3787–99 (1999).

  24. 24.

    Yoshida, H. et al. A time-dependent phase shift in the mammalian unfolded protein response. Dev Cell 4, 265–71 (2003).

  25. 25.

    Molero, X. et al. Pancreas transcription factor 1alpha expression is regulated in pancreatitis. Eur J Clin Invest 37, 791–801 (2007).

  26. 26.

    Seyhun, E. et al. Tauroursodeoxycholic acid reduces endoplasmic reticulum stress, acinar cell damage, and systemic inflammation in acute pancreatitis. Am J Physiol Gastrointest Liver Physiol 301, G773–82 (2011).

  27. 27.

    Soriano, P. Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat Genet 21, 70–1 (1999).

  28. 28.

    Stanger, B. Z. et al. Pten constrains centroacinar cell expansion and malignant transformation in the pancreas. Cancer Cell 8, 185–95 (2005).

  29. 29.

    Luche, H., Weber, O., Nageswara Rao, T., Blum, C. & Fehling, H. J. Faithful activation of an extra-bright red fluorescent protein in “knock-in” Cre-reporter mice ideally suited for lineage tracing studies. Eur J Immunol 37, 43–53 (2007).

  30. 30.

    Fujiyama, T. et al. Forebrain Ptf1a Is Required for Sexual Differentiation of the Brain. Cell Rep 24, 79–94 (2018).

  31. 31.

    Furuyama, K. et al. Continuous cell supply from a Sox9-expressing progenitor zone in adult liver, exocrine pancreas and intestine. Nat Genet 43, 34–41 (2011).

  32. 32.

    Goto, T. et al. Liver-specific Prox1 inactivation causes hepatic injury and glucose intolerance in mice. FEBS Lett 591, 624–635 (2017).

Download references

Acknowledgements

This work was supported by the Funding Program for Next Generation World-Leading Researchers, Japan Society for the Promotion of Science [grant number LS063]. We thank P. Karagiannis for proofreading, and the staff of the Institute of Laboratory Animals at Graduate School of Medicine, Kyoto University, for animal care. The electron microscopy study was supported by Keiko Okamoto-Furuta and Haruyasu Kohda (Division of Electron Microscopic Study, Center for Anatomical Studies, Graduate School of Medicine, Kyoto University).

Author information

Y.K. and M.S. designed the study, analyzed the data and prepared the manuscript. M.S. performed the experiments. Y.D. generated the mice. T.F. and Mi.H. generated the Ptf1afloxed mice. Mi.H. provided the anti-PTF1A antibody. K.F., Ma.H., S.H., Y.A., K.T., T.G., K.H. and T.M. gave technical support and discussion. S.U. and Y.K. supervised the project.

Competing Interests

The authors declare no competing interests.

Correspondence to Yoshiya Kawaguchi.

Electronic supplementary material

supplementary information

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.